Accession Number: | 0001209191-19-039152 |
Date: | 2019-06-25 |
Issuer: | CARDLYTICS, INC. (CDLX) |
Original Submission Date: |
JOHNSON MARK A
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA, GA 30308
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2019-06-25 | deemed execution date | A | 6,353 (a) | common stock 6,353 | $0.00 | 6,353 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit ("rsu") represents a contingent right to receive one share of common stock of the issuer, or at the election of the issuer, its cash equivalent. |
f2 | the rsus shall vest in full on the one-year anniversary of the date of grant, provided that the reporting person remains a director of the issuer on such vesting date. |